Optimum Treatment for Drug-Resistant Hypertension

NCT02369081 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

348

Enrollment

OTHER

Sponsor class

Conditions

Hypertension, Resistant to Conventional Therapy

Interventions

DRUG: Spironolactone
DRUG: Bisoprolol
DRUG: Doxazosin
DRUG: Placebo

Sponsor

University of Cambridge

Collaborators

[object Object]